RT Journal Article
SR Electronic
T1 Should anticoagulation be resumed after intracerebral hemorrhage?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 791
OP 799
DO 10.3949/ccjm.77a.10018
VO 77
IS 11
A1 Joshua N. Goldstein
A1 Steven M. Greenberg
YR 2010
UL http://www.ccjm.org/content/77/11/791.abstract
AB Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation- associated ICH.